Featured Genomics & Sequencing Services
High-throughput library preparation, automated DNA/RNA extraction, and complete transcriptomic profiling solutions for European researchers.
Overview of Long Non-Coding RNA Sequencing in Modern Genomics
Long non-coding RNAs (lncRNAs) are defined as non-protein-coding RNA transcripts exceeding 200 nucleotides in length. Once dismissed as transcriptional "noise," lncRNAs are now recognized as master regulators of gene expression, acting at transcriptional, post-transcriptional, and epigenetic levels. Through chromatin remodeling, microRNA sponging, structural scaffolding, and protein interaction, lncRNAs modulate complex biological pathways involved in oncology, neurobiology, cardiovascular biology, and immunology.
Comprehensive transcriptomic exploration of lncRNAs poses unique bioinformatic and experimental challenges. Unlike abundance-rich messenger RNAs (mRNAs), lncRNAs frequently exhibit lower expression levels, cell-type-specific activity, and intricate structural isoforms. Standard poly-A selection methods often fail to capture non-polyadenylated lncRNA species. Consequently, high-depth strand-specific RNA sequencing paired with ribosomal RNA depletion (ribo-zero) has become the gold standard for full-spectrum lncRNA discovery and quantification.
Key Insight for Swiss Life Scientists: Complete lncRNA characterization requires high sequence depth, precise strand orientation, and robust bioinformatic workflows capable of distinguishing novel lncRNA transcripts from unannotated protein-coding fragments and background genomic noise.
Switzerland’s Life Science Ecosystem & Industrial Demand for lncRNA Services
Switzerland stands as a preeminent global epicenter for pharmaceutical research, biotechnology innovation, and academic science. The Swiss Biotech Cluster—spanning the pharmaceutical hubs of Basel, the technological ecosystem of Zurich, and the dynamic "Health Valley" across the Lake Geneva region (Lausanne and Geneva)—creates an unmatched environment for multi-omics implementation.
Leading academic institutes such as ETH Zurich, EPFL (École polytechnique fédérale de Lausanne), the University of Basel, University of Zurich, and the University of Geneva continuously push the frontiers of non-coding RNA research. Simultaneously, major pharmaceutical leaders (including Novartis and Roche) and numerous high-growth Swiss biotechs actively pursue non-coding target discovery for next-generation RNA therapeutics, antisense oligonucleotides (ASOs), and novel diagnostic biomarkers.
Key Local Application Scenarios in Switzerland
- Oncology & Precision Biomarker Discovery: Swiss clinical research centers rely heavily on lncRNA differential expression analysis to identify tissue-specific tumor markers. Dysregulated lncRNAs like HOTAIR, MALAT1, and PCA3 serve as key novel therapeutic targets and non-invasive liquid biopsy biomarkers in Swiss oncology trials.
- Neuroscience & Neurodegenerative Disease Research: With world-class brain research initiatives focused on Alzheimer’s, Parkinson’s, and ALS at EPFL and ETH Zurich, strand-specific lncRNA sequencing provides insight into epigenetic regulation, neural cell fate determination, and synaptic plasticity impairment.
- Cardiovascular & Metabolic Medicine: Swiss cardiovascular research groups utilize deep RNA sequencing to map non-coding transcriptional shifts associated with vascular inflammation, cardiac hypertrophy, and metabolic dysregulation.
- Agricultural & Plant Genomics: Supported by institutions like the Swiss Federal Research Station Agroscope and agricultural science departments, lncRNA sequencing plays a vital role in understanding environmental stress responses, crop resistance mechanisms, and plant breeding programs.
Technology Trends & Innovations Shaping lncRNA Sequencing
The global and Swiss lncRNA sequencing landscape is undergoing rapid technological transformation. Researchers no longer settle for basic expression counting; they demand structural, spatial, and single-cell resolution to unlock therapeutic mechanisms.
Full-Length Isoform Resolution
Integration of long-read PacBio Iso-Seq and Oxford Nanopore platforms allows complete reconstruction of full-length lncRNA splicing isoforms without assembly ambiguity.
Spatial & Single-Cell Transcriptomics
Technologies like BMKMANU S3000 spatial transcriptomics enable mapped lncRNA expression directly within intact tissue architecture, preserving spatial biological context.
AI-Powered Bioinformatic Clouds
Automated cloud analysis via BMKCloud facilitates rapid machine-learning target prediction, lncRNA-miRNA-mRNA co-expression networks, and functional gene ontology mapping.
Biomarker Technologies (BMKGene) Profile & Infrastructure
Biomarker Technologies (BMKGene), founded in 2009, is a leading genomics service provider with over 16 years of continuous innovation in high-throughput sequencing and bioinformatics. Backed by more than 60 national invention patents and 200+ software copyrights, we deliver comprehensive multi-omics solutions—spanning genomics, metagenomics, epigenetics, single-cell omics, transcriptomics, and our proprietary BMKMANU S3000 spatial transcriptome technology—supported by our advanced BMKCloud bioinformatics platform. We have established long-term collaborations with organizations across 84 regions worldwide, providing reliable genomic solutions on a global scale.
State-of-the-Art Multi-Platform Sequencing Capacity
To meet the diverse requirements of Swiss academic and commercial clients, BMKGene operates an extensive laboratory setup featuring world-leading sequencing technologies:
PacBio & Nanopore Long-Read
PacBio: Sequel II, Sequel, RSII
Nanopore: PromethION P48, GridION X5, MinION
Ideal for full-length transcript isoform identification and T2T genome assembly.
Illumina & BGI Short-Read
Illumina: NovaSeq Series
BGI-Sequencing: DNBSEQ-G400, DNBSEQ-T7
Ultra-deep sequencing yield for differential lncRNA profiling and short RNA discovery.
Single-Cell & Bio-Analytics
Single Cell: 10X ChromiumX, 10X Controller
Optical Mapping: Bionano Irys system
Mass Spec: Waters XEVO G2-XS QTOF, QTRAP 6500+
Over 20,000 Square Feet Laboratory Infrastructure
Standardized biomolecular laboratory spaces including dedicated sample extraction rooms, library construction clean rooms, and high-capacity sequencing floors governed by strict SOPs and ISO-certified management protocols.
Fully Automated NGS Platform: Brilliant Lab 1000 (BL1000)
Biomarker Technologies (BMKGene) and PerkinElmer have jointly built a fully automated experimental production line, called Brilliant Lab 1000 (BL1000), which is applied to high-throughput NGS library construction services.
Through robotic liquid handling, automated magnetic bead purification, and intelligent sample tracking, BL1000 minimizes human error, standardizes library quality, and significantly reduces project turnaround times for our Swiss partners.
BMKGene strives to greatly improve the entire line of sequencing products in terms of product types, production line throughput, delivery quality, and cycle time, to provide Swiss academic and pharma customers with industry-leading sequencing solutions.
Streamlined Quotation & Project Execution for Swiss Clients
From sample shipment in Basel, Zurich, or Lausanne to final bioinformatic delivery on BMKCloud.
Quote Request
Submit project scope, sample numbers, and sequencing depth requirements for tailored Swiss pricing.
Sample Logistics
Compliant cold-chain sample transport protocols from Swiss research institutes to our ISO-certified facilities.
Strict QC & Library
Rigorous RNA integrity (RIN) verification followed by strand-specific ribo-depleted library prep.
High-Depth NGS
Sequencing on NovaSeq or long-read platforms ensuring maximum coverage for low-abundance lncRNAs.
BMKCloud Data
Interactive bioinformatic reports, target prediction, pathway enrichment, and raw fastq file delivery.
Self-Developed BMKCloud Bioinformatics Platform
Equipped with CPUs featuring 41,104 memory, 3 PB total storage capacity, and 4,260 computing cores delivering peak processing power over 121,708.8 Gflops per second for ultra-fast bioinformatic turnarounds.
Enterprise Qualifications & Accreditations
Certified operational excellence, ISO quality standards, and intellectual property backing our global sequencing services.
High-Throughput Sequencing Facilities
A glimpse inside our standard laboratories for sample extraction, library construction, clean rooms, and high-throughput sequencing operations.
Complete Transcriptomic & Multi-Omics Services
Explore our full range of molecular biology kits and high-throughput sequencing solutions available for global and Swiss institutions.
Get Your Long Non‑Coding RNA Sequencing Quote in Switzerland
For inquiries about our lncRNA sequencing services, batch volume pricing, or custom bioinformatic pipelines, leave your email below. Our team will contact you within 24 hours.
